Al Dawaa Medical Services Co.
"Sector" = median of Healthcare across 84 companies
About Al Dawaa Medical Services Co.
AI-generatedAl Dawaa Medical Services Co. is a leading pharmaceutical retailer in Saudi Arabia, operating a network of retail pharmacies under the Al Dawaa brand. The company also engages in wholesale distribution of pharmaceutical products, medical equipment, and cosmetics. Founded in 1994 and headquartered in Riyadh, it is one of the largest pharmacy chains in the Kingdom, serving both walk-in customers and institutional clients.
The company generates revenue primarily from the sale of prescription and over-the-counter drugs, which account for the majority of sales. Other revenue streams include cosmetics, personal care products, medical supplies, and wholesale distribution to hospitals and clinics. With over 1,200 outlets across Saudi Arabia, Al Dawaa benefits from high foot traffic and repeat purchases. The recent quarterly revenues have been stable around 1.7 billion SAR, indicating a mature and resilient business model.
Al Dawaa operates in the pharmaceutical retail sector, a sub-industry of healthcare. The sector is characterized by regulatory oversight from the Saudi Food and Drug Authority and competition from other pharmacy chains like Nahdi Medical and Al Nahdi, as well as independent pharmacies. Al Dawaa holds a strong market position due to its extensive store network, brand recognition, and strategic locations. The company's margins are typical for the sector, with a gross margin of 34.8% and operating margin of 6.0%.
The company's primary customers are individual consumers seeking prescription medications and health products. It also serves hospitals, clinics, and government entities through its wholesale division. Geographically, Al Dawaa's operations are concentrated in Saudi Arabia, with a focus on major cities and urban areas. The company has limited international exposure, relying on the domestic market's growing healthcare demand driven by population growth and government initiatives.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: March 2026 · 2026-03-31
Dividend history
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Feb 11, 2026 | 0.63 SAR | — | — |
| Nov 10, 2025 | 0.63 SAR | — | — |
| Aug 12, 2025 | 0.63 SAR | — | — |
| May 21, 2025 | 0.63 SAR | — | — |
| Feb 11, 2025 | 0.63 SAR | — | — |
| Nov 12, 2024 | 0.63 SAR | — | — |
| Aug 12, 2024 | 0.63 SAR | — | — |
| Feb 13, 2024 | 1.25 SAR | — | — |
| Sep 12, 2023 | 1.25 SAR | — | — |
| Apr 5, 2023 | 1.25 SAR | — | — |
| Sep 6, 2022 | 1.25 SAR | — | — |
Revenue
↓ 5.4%Net Income
↓ 70.4%Free Cash Flow
↑ 19.3%Diluted EPS
↓ 70.5%Al Dawaa Medical Services Co. (4163) analysis
Wrqti brings Al Dawaa Medical Services Co. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Stocks related to Al Dawaa Medical Services Co.
Companies in the Healthcare sector you can compare with Al Dawaa Medical Services Co.: